Real world evidence of long-term benefits from allergen-specific immunotherapy (AIT)

Real world evidence of long-term benefits from allergen-specific immunotherapy (AIT)

Bibliographic Details
Main Author:	Guy Scadding
Format:	Article
Language:	English
Published:	Elsevier 2022-02-01
Series:	The Lancet Regional Health. Europe
Online Access:	http://www.sciencedirect.com/science/article/pii/S2666776221002696

Similar Items

Allergen Immunotherapy (AIT): a prototype of Precision Medicine
by: GW Canonica, et al.
Published: (2015-01-01)

Vitamin D Role in Childhood Mite Allergy and Allergen Immunotherapy (AIT)
by: Claudia Petrarca, et al.
Published: (2023-06-01)

Allergen-specific immunotherapy provides immediate, long-term and preventive clinical effects in children and adults: the effects of immunotherapy can be categorised by level of benefit -the centenary of allergen specific subcutaneous immunotherapy
by: Jacobsen Lars, et al.
Published: (2012-04-01)

Long-term benefit after allergen immunotherapy to HDM in elderly patients with allergic rhinitis
by: Andrzej Bożek, et al.
Published: (2023-07-01)

Allergen-specific immunotherapy
by: Moote William, et al.
Published: (2011-11-01)

Allergen Specific Immunotherapy
by: Esther Helen Steveling-Klein
Published: (2016-12-01)

Mechanisms of allergen-specific immunotherapy and allergen tolerance
by: Umut C. Kucuksezer, et al.
Published: (2020-10-01)

Allergen Immunotherapy (AIT) in children: a vulnerable population with its own rights and legislation – summary of EMA-initiated multi-stakeholder meeting on Allergen Immunotherapy (AIT) for children, held at Paul-Ehrlich-Institut, Langen, Germany, 16.1.2019
by: V. Mahler, et al.
Published: (2020-06-01)

Future of allergen-specific immunotherapy
by: Takeru Ishikawa
Published: (1998-01-01)

Allergen-specific immunotherapy: regulatory T cells or allergen-specific IgG?
by: Kündig, T, et al.
Published: (2010)

Allergen-specific immunotherapy: State of the art
by: Roberto Bernardini, et al.
Published: (2024-03-01)

Broad perspectives of allergen specific immunotherapy
by: Wayne Robert Thomas
Published: (2017-10-01)

ALLERGEN-SPECIFIC IMMUNOTHERAPY IN CHILDREN WITH POLLINOSIS
by: R. M. Torshkhoeva, et al.
Published: (2014-01-01)

Allergen-specific immunotherapy in allergic rhinitis
by: V. V. Klimov, et al.
Published: (2022-07-01)

Diverse Mechanisms of Allergen Specific Immunotherapy
by: Lacin Cevhertas, et al.
Published: (2019-12-01)

Allergen-Specific Immunotherapy in Food Anaphylaxis
by: Regina Kerzl, et al.
Published: (2008-01-01)

Predicting Success of Allergen-Specific Immunotherapy
by: Ulrich M. Zissler, et al.
Published: (2020-08-01)

Systemic reactions to subcutaneous allergen immunotherapy: real-world cause and effect modelling
by: Adam Aue, et al.
Published: (2021-07-01)

The Molecular Allergen Recognition Profile in China as Basis for Allergen-Specific Immunotherapy
by: Nishelle D’souza, et al.
Published: (2021-08-01)

Effectiveness of allergen-specific immunotherapy with pollen allergens in children from the viewpoint of molecular allergology
by: S.M. Nedelska, et al.
Published: (2017-03-01)

Real-World Safety and Efficacy Clinical Data of an Improved Allergen-Specific Immunotherapy Product for the Treatment of Bee Venom Allergy
by: Luis Alfredo Gonzalez Guzman, et al.
Published: (2023-05-01)

Persistence in allergen immunotherapy: A longitudinal, prescription data‐based real‐world analysis
by: Oliver Pfaar, et al.
Published: (2023-05-01)

ALLERGEN-SPECIFIC IMMUNOTHERAPY: VACCINES FOR ALLERGIC DISEASES
by: A. S. Fedorov, et al.
Published: (2015-10-01)

A Review of Allergy and Allergen Specific Immunotherapy
by: Katayoon Bidad, et al.
Published: (2011-03-01)

Shared Decision-Making in Allergen Immunotherapy (AIT) Options Using a Questionnaire for Respiratory Allergic Patients: A Delphi Consensus Study
by: Antón M, et al.
Published: (2023-07-01)

Encapsulation of Allergens into Core–Shell Chitosan Microparticles for Allergen-Specific Subcutaneous Immunotherapy
by: Mariya Konovalova, et al.
Published: (2023-05-01)

Possibilities of sublingual allergen-specific immunotherapy in preschool children with sensitization to mold fungus allergens
by: O. V. Sharikadze, et al.
Published: (2020-06-01)

Successful Allergen-Specific Immunotherapy: Induction of Unresponsiveness by ‘Vaccination’
by: Martin F. Bachmann, et al.
Published: (2023-12-01)

Allergen-specific immunotherapy: history, methods and new options
by: O. M. Kurbacheva, et al.
Published: (2013-12-01)

Quality of life of patients subjected to specific allergen immunotherapy
by: Barbara Kubik, et al.
Published: (2017-12-01)

The intriguing possibility of using probiotics in allergen-specific immunotherapy
by: Fabiana Furci, MD, et al.
Published: (2023-02-01)

Immunological Outcomes of Allergen-Specific Immunotherapy in Food Allergy
by: Ann-Marie Malby Schoos, et al.
Published: (2020-11-01)

Allergen-specific immunotherapy: an update on immunological mechanisms of action
by: G. Ciprandi, et al.
Published: (2016-02-01)

Allergen specificity is relevant for immunotherapy prescription in polysensitised children
by: Ciprandi Giorgio, et al.
Published: (2012-09-01)

Allergen specific immunotherapy induced multi-organ failure
by: Aissa Sana, et al.
Published: (2013-04-01)

Intradermal Allergen Immunotherapy for Allergic Rhinitis: Current Evidence
by: Kawita Atipas, et al.
Published: (2022-08-01)

Allergens and allergen immunotherapy : subcutaneous, sublingual, and oral /
by: Lockey, Richard F., editor, et al.
Published: (2014)

Decorating and loading ghosts with allergens for allergen immunotherapy
by: Songwe Fanuel, et al.
Published: (2017-10-01)

Nanoparticle–allergen complexes for allergen immunotherapy
by: Di Felice G, et al.
Published: (2017-06-01)

Allergen Content of Therapeutic Preparations for Allergen-Specific Immunotherapy of European Paper Wasp Venom Allergy
by: Johannes Grosch, et al.
Published: (2022-04-01)